Postantibiotic effect of levofloxacin against pneumococci

Drugs

Volumn 58, Issue SUPPL. 2, 1999, Pages 378-380

  Spangler, S K ^a   Lin, G ^a   Jacobs, M R ^a   Appelbaum, P C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

CONFERENCE PAPER; NONHUMAN; POSTANTIBIOTIC EFFECT; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

EID: 0032708167     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199958002-00130     Document Type: Conference Paper

References (9)

1. 1. PC Appelbaum 1992 Antimicrobial resistance in Streptococcus pneumoniae — an overview Clin Infect Dis 15 77 83 1617076 10.1093/clinids/15.1.77 1:STN:280:DyaK38zhsVamug%3D%3D Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae — an overview. Clin Infect Dis 1992; 15: 77–83
2. 2. GV Doern A Brueggeman HP Holley 1996 Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study Antimicrob Agents Chemother 40 1208 13 8723468 1:CAS:528:DyaK28XislClt7w%3D Doern GV, Brueggeman A, Holley, HP, et al. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996; 40: 1208–13
3. 3. MR Jacobs PC Appelbaum 1995 Antibiotic-resistant pneumococci Rev Med Microbiol 6 77 93 10.1097/00013542-199504000-00001 Jacobs MR, Appelbaum PC. Antibiotic-resistant pneumococci. Rev Med Microbiol 1995; 6: 77–93
4. 4. KP Fu SC Lafredo B Foleno 1992 In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin. Antimicrob Agents Chemother 36 860 6 1503449 10.1128/AAC.36.4.860 1:CAS:528:DyaK38XisFWqur4%3D Fu KP, Lafredo SC, Foleno B, et al. In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin. Antimicrob Agents Chemother 1992; 36: 860–6
5. 5. K Fuursted JD Knudsen MB Petersen 1997 Comparative study of bactericidal activities, postantibiotic effects, and effects on bacterial virulence of penicillin G and six macrolides against Streptococcus pneumoniae. Antimicrob Agents Chemother 41 781 4 9087489 1:CAS:528:DyaK2sXitlaksrs%3D Fuursted K, Knudsen JD, Petersen MB, et al. Comparative study of bactericidal activities, postantibiotic effects, and effects on bacterial virulence of penicillin G and six macrolides against Streptococcus pneumoniae. Antimicrob Agents Chemother 1997; 41: 781–4
6. 6. L Licata CE Smith RM Goldschmidt 1997 Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylocccus aureus and Streptococcus pneumoniae. Antimicrob Agents Chemother 41 950 5 9145850 1:CAS:528:DyaK2sXjtVCntLk%3D Licata L, Smith CE, Goldschmidt RM, et al. Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylocccus aureus and Streptococcus pneumoniae. Antimicrob Agents Chemother 1997; 41: 950–5
7. 7. WA Craig S Gudmundsson 1996 Postantibiotic effect V Lorian Antibiotics in laboratory medicine Williams and Wilkins Baltimore 296 329 Craig WA, Gudmundsson S. Postantibiotic effect. In: Lorian V, editor. Antibiotics in laboratory medicine. Baltimore: Williams and Wilkins, 1996; 296–329
8. 8. I Odenholt-Tornqvist E Löwdin O Cars 1992 Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin and amikacin Antimicrob Agents Chemother 36 1852 8 1329631 10.1128/AAC.36.9.1852 1:CAS:528:DyaK3sXjsV2j Odenholt-Tornqvist I, Löwdin E, Cars O. Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin and amikacin. Antimicrob Agents Chemother 1992; 36: 1852–8
9. 9. J Child D Mortiboy JM Andrews 1995 Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid Antimicrob Agents Chemother 39 2749 51 8593013 10.1128/AAC.39.12.2749 1:CAS:528:DyaK2MXpslOhtbs%3D Child J, Mortiboy D, Andrews JM, et al. Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid. Antimicrob Agents Chemother 1995; 39: 2749–51